Skip 
Navigation Link
Drug Addiction
Resources
Basic InformationLatest News
Immediate Access to Opioid Agonists Found Cost-EffectiveOpioid Crisis Hitting Boomers, Millennials HardestTop Anti-Opioid Meds Are Equally Safe, EffectiveIs Meth Use Destroying Vets' Hearts?Health Tip: Spread Awareness of the Opioid EpidemicLethal Dangers Lurk Even After Opioid OD RescueUsing Cocaine? Fingerprints Might TellFentanyl Driving Surge in Fatal U.S. Opioid OverdosesTrump Declares Opioid Epidemic a Public Health EmergencyU.S. Opioid Painkiller Abuse May Be Leveling OffDrug OD Rate Now Higher in Rural U.S. Than Cities: CDCExtended-Release Naltrexone Promising for Opioid DependenceHealth Tip: Recovering From Substance AbuseMedicare Could Do More to Stem Opioid EpidemicOpioid Manufacturers to Provide Doctor TrainingHeroin Taking Bigger Share of U.S. Opioid ODsRapid Test for Meth Abuse May Be NearOpioid ODs Have Cut Into U.S. Life Expectancy: CDCFDA Permits Marketing of App to Help Treat Substance AbuseApp to Help Treat Substance Abuse ApprovedFentanyl Drives Rise in Opioid-Linked Deaths in U.S.Opioid Overdoses and Deaths Flooding U.S. HospitalsU.S. Opioid Crisis Continues to Worsen'12-Step' Strategy Boosts Success of Teen Drug Abuse ProgramAddiction Drug Underused by Primary Care Docs in U.S.Is Infant Drug Withdrawal Likelier When Opioids Used With Psychiatric Drugs?7-Fold Spike Seen in Opioid-Linked Fatal Car CrashesOpioid Abuse Down in Younger Americans, But Up Among Older AdultsHospitalists Have Role to Play in Mitigating Opioid Use DisorderOpioids Second Only to Marijuana in Illicit Drug Abuse RatesEnding U.S. Opioid Abuse Epidemic Will Take Years: ReportMore Research Shows Big Surge in U.S. Opioid Use, AddictionsOpioid Addicts Find It Hard to Avoid FentanylAddicts Try to Avoid Deadly Fentanyl, But Many Tragically FailMedical Costs Soar for U.S. Babies Born Addicted to OpioidsAs U.S. Heroin Use Reaches 20-Year High, Cost to Society SoarsHeroin Vaccine Blocks Drug High in Tests on MonkeysDid a 1980 Letter Help Spark the U.S. Opioid Crisis?New FDA Head Outlines 'Forceful Steps' Against Opioid CrisisChecking Patient's Drug History May Help Curb Opioid Abuse1 in 4 Americans Knows Someone Hooked on Opioids: PollIt's Often Family to the Rescue During Opioid ODsGuidelines Issued on Substance Use Disorder Treatment in NursesBabies Born Addicted to Opioids Often Struggle With LearningDrug-Impaired Driving Continuing to Rise in the United StatesAMA Urges Doctors to Talk About Safe Opioid Storage, DisposalDrugs Now Involved in More Fatal U.S. Crashes Than Alcohol AloneHigher Illicit Pot Use in States That OK Medical Marijuana: StudyTrump Administration Offers Grants to Fight Opioid CrisisOpioid Abusers at Higher Death Risk When Addiction Specialists Not Part of Care
Links
Related Topics

Patients With Opioid Addiction Benefit From Tx Initiated in ER


HealthDay News
Updated: Feb 21st 2017

new article illustration

TUESDAY, Feb. 21, 2017 (HealthDay News) -- Patients addicted to opioids treated in a hospital emergency department do better when they receive medication to reduce opioid cravings, according to a study published online Feb. 13 in the Journal of General Internal Medicine.

The study looked at 290 patients addicted to opioids who went to an emergency department. They received one of three treatments: a referral to addiction treatment services; a short interview, including discussion of treatment; or a brief interview and the medication buprenorphine. The patients given medication also continued treatment with their primary care doctor.

After two months of follow-up, the researchers found that patients who received buprenorphine were more likely to be in formal addiction treatment and to report reduced opioid use than those in the other two groups.

"The emergency department visit is an ideal opportunity to identify patients with opioid use disorder and initiate treatment and direct referral, similar to best practices for other diseases, such as high blood pressure and diabetes," study co-leader Gail D'Onofrio, M.D., chair of emergency medicine at the Yale School of Medicine in New Haven, Conn., said in a Yale news release.

The study was supported by the National Institute on Drug Abuse (NIDA). Reckitt Benckiser Pharmaceuticals provided buprenorphine through the NIDA.

Abstract/Full Text (subscription or payment may be required)